BridgeMD
Compares treatment options for Total Knee Arthroplasty
Official title Femoral Triangle Block vs Adductor Canal Block on Early Quadriceps Function After Total Knee Arthroplasty
ClinicalTrials.gov ID: NCT07524387
What this study is testing
- What it's testing
- The goal of this clinical trial is to compare the effects of femoral triangle block (FTB) and adductor canal block (ACB) on early quadriceps function after total knee arthroplasty (TKA). The main question it aims to answer is whether FTB causes more early quadriceps functional impairment than ACB under a standardized multimodal analgesia protocol.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 and older
You may be able to join if
- Adult patients (≥ 20 years of age) are scheduled to undergo primary unilateral TKA.
- American Society of Anesthesiologists (ASA) physical status I-III.
- Ability to ambulate independently prior to surgery.
- Ability to understand the study procedures and provide written informed consent.
- Planned perioperative anesthesia management including regional anesthesia as part of standard clinical care.
You likely can't join if
- Known allergy or contraindication to local anesthetic agents used in this study.
- Pre-existing neurological or neuromuscular disorders affect lower limb strength or motor control.
- Severe cognitive impairment or psychiatric conditions interfere with study participation or assessment.
- History of revision knee arthroplasty on the operative side.
- Severe preoperative quadriceps weakness that precludes reliable baseline strength assessment.
- Any condition deemed by the investigator to make participation inappropriate.
See the full eligibility criteria
- Adult patients (≥ 20 years of age) are scheduled to undergo primary unilateral TKA.
- American Society of Anesthesiologists (ASA) physical status I-III.
- Ability to ambulate independently prior to surgery.
- Ability to understand the study procedures and provide written informed consent.
- Planned perioperative anesthesia management including regional anesthesia as part of standard clinical care.
- Ability to extend the knee below 30 degrees preoperatively (no knee extension contracture)
- Known allergy or contraindication to local anesthetic agents used in this study.
- Pre-existing neurological or neuromuscular disorders affect lower limb strength or motor control.
- Severe cognitive impairment or psychiatric conditions interfere with study participation or assessment.
- History of revision knee arthroplasty on the operative side.
- Severe preoperative quadriceps weakness that precludes reliable baseline strength assessment.
- Any condition deemed by the investigator to make participation inappropriate.
The study team makes the final eligibility decision.
Where it's taking place
- Ichinomiya, Aichi-ken, Japan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ichinomiya, Aichi-ken, Japan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.